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Abstract
The convergence of HIV-1 budding and exosome biogenesis at late endosomal compartments called multivesicular
bodies has fueled the debate on whether HIV-1 is budded from its target cells and transmitted in the form of exo-
somes. The point of contention appears to primarily derive from the types of target cells in question and lack of a
well-defined protocol to separate exosomes from HIV-1. In this study, we adapted and established a simplified pro-
tocol to define the relationship between HIV-1 production and exosome biogenesis. Importantly, we took advan-
tage of the newly established protocol to unequivocally show that HIV-1 was produced from CD4+ T lymphocytes
Jurkat cells independently of exosomes. Thus, this study not only presents a simplified way to obtain highly puri-
fied HIV-1 virions for identification of host proteins packaged into virions, but also provides a technical platform
that can be employed to define the relationship between exosome biogenesis and budding of HIV-1 or other
viruses and its contributions to viral pathogenesis.
Text
Exosomes were initially identified as small membrane
vesicles from immature red blood cells [1] and have since
been detected in various mammalian cells, tissues and
physiological fluids [see a recent review [2]]. They are
originated from multivesicular bodies through direct
fusion with plasma membrane [3,4], with sizes ranging
between 30 and 100 nm [5,6]. Several important func-
tions have been attributed to these small vesicles, these
include protein homeostasis [7], humoral immune
response [5,8-10], cell-cell interaction [11,12], and anti-
tumor activity [6]. In addition, exosomes have also been
proposed to play an important role in HIV-1 budding
and infection [13], as exosomes and HIV-1 converge at
the endosomes and share similar host lipid and protein
compositions [10,14]. In macrophages and dendritic cells,
HIV-1 was shown to bud into the endosomes [15-20]
and secreted in the form of exosomes [21-23]. Recently, a
consensus has emerged that HIV-1 does not bud into
endosomes but to an external compartment [24,25]. To
the contrary, the findings in CD4+ T lymphocytes are
quite inconsistent and uncertain. Some studies suggest
that HIV-1 is budded from T cell plasma membrane and
does not involve endosomes and exosomes [26-31], while
others show that T cells produce HIV-1 in close associa-
tion with exosomes, similarly to that in macrophages and
dendritic cells [32-34]. The inconsistency concerning the
relationship between HIV-1 budding and exosome bio-
genesis conceivably is likely due to cross-contamination
of each other during isolation and purification as a result
of their indistinguishable sizes and densities [35,36].
Thus, to define the precise role of exosomes in HIV-1
budding, transmission and other virol-immunological
processes, it is imperative to establish a simplified and
reproducible protocol that allows clear separation of
exosomes from HIV-1.
Several ways have been exploited to study HIV-1
interaction with exosomes. The general approach is a
step-wise protocol, which is composed of first brief low-
speed centrifugation to remove cells and cell debris
from the cell culture supernatant, then filtration by pas-
sing the cleared through a 0.22 nm filter, and lastly
high-speed centrifugation to obtain exosomes and/or
HIV-1 virions. The presence of exosomes, HIV-1, or
both is evaluated by detection of exosome markers, and
HIV-1 viral antigens, and electron microscopic imaging.
In this study, we introduced a modified protocol that
allows successful separation of HIV-1 virions from exo-
somes. Similar protocols have been widely employed to
isolate or concentration HIV-1 virions.
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viruses equivalent to 10,000 cpm reverse transcriptase
(RT) activity and cultured for 7-9 days when virus repli-
cation was peaked (data not shown). The cell culture
supernatant was collected and first centrifuged at 800 g
for 10 min to remove cells and cell debris. The cleared
supernatant was then passed through a 0.22 μmf i l t e r
(Corning, NY) to ensure complete removal of smaller
cell debris. The pass-through supernatant was loaded
onto 1 ml 20% sucrose in PBS and centrifuged with a
SW55Ti (Beckman, NY) at 238,000 g for 90 min to
obtain the virion preparation (S). To compare virion
compositions, a same volume of the cleared supernatant
from the first centrifugation and the pass-through from
the filtration was loaded onto 1 ml PBS and subjected
to the same last step high-speed centrifugation to obtain
virion preparation C and F, respectively. All three virion
preparations were suspended in the SDS-PAGE sample
buffer for Western blot analysis. Using the highly abun-
dant b-actin protein as an exosomal marker [2,37,38],
we detected exosomes in virion preparations C and F,
but not in virion preparation S (Figure 1A). Importantly,
we detected a comparable level of HIV-1 p24 in all
three virion preparations (Figure 1A), as well as a com-
parable level of RT activity among all three virion pre-
parations (Figure 1B). These results together show that
the high-speed centrifugation with the 20% sucrose
cushion at the last step gives rise to HIV-1 virions
Figure 1 HIV-1 production and exosome biogenesis in Jurkat cells. A.J u r k a tc e l l sw e r ei n f e c t e dw i t hH I V - 1H X B 2v i r u s e s( H I V )o rm o c k
infected (CM). Cells (c) were harvested and culture supernatants (sp) were collected 9 days after infection. Culture supernatants were first cleared
of cells and debris by low-speed centrifugation, followed by filtration and further 20% sucrose sedimentation. The virion preparations from these
three steps were C, F, and S, respectively. Cell lysates and virion preparations were subjected to Western blotting using antibodies against HIV-1
p24 or b-actin (upper: sucrose banding for 1 hr; lower: sucrose banding for 2.5 hr). *: p24 precursors. B. HIV-1 RT assay of three virion
preparations. C. Acetylcholinesterase (AChe) activity assay of the virus preparations F and S as well as the sucrose cushion from sucrose
sedimentation (S*). D. Jurkat cells were inoculated with each of three virus preparations (corresponding to 10,000 cpm of RT activity) and
monitored for virus infection and replication.
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exosome hypothesis. We also included the lysates from
HIV-1-infected Jurkat cells (HIVc) and mock-infected
Jurkat cells (CMc), as well as the pellets of supernatants
from mock-infected Jurkat cells (CMsp), as controls in
the experiments. Longer high-speed centrifugation at
the last step, i.e., 2.5 hr, did not change the b-actin dis-
tribution pattern (bottom, Figure 1A).
To confirm that the new protocol did lead to successful
separation of HIV-1 virions from exosomes, we further
analyzed virion preparations F and S for the presence of
exosomes using the other well-documented exosome
marker, acetylcholinesterase (AChe) [1,31]. We found a
significant level of AChe activity in virion preparation F
but a much lower level of AChe activity in virion prepara-
tion S (Figure 1C). The Ache activity in preparation F and
S showed little changes between the mock- and HIV-1-
infected samples. To ensure that exosomes were comple-
tely separated from HIV-1 virions and thereby remained
in the sucrose cushion (S*), we further analyzed the AChe
activity in the sucrose cushion and detected a level of
AChe activity in the sucrose cushion comparable to that
in preparation F (Figure 1C), verifying a clear separation of
HIV-1 from exosomes by the new protocol. This was
further supported by Western blotting analysis that
b-actin was detected in preparation S* with a comparable
intensity to that in preparation F in mock-infected sam-
ples, indicating that almost all exosomes in preparation F
were separated from virions and recovered in preparation
S* (Insert in Figure 1C). We obtained similar results from
HIV-infected samples (data not shown). Using another
exosome marker, heat shock protein 70 (Hsp70) [38-41],
we also obtained similar results (data not shown). To
further ascertain independent release of HIV-1 virions
from exosomes, we fixed and negative stained both F and
S virion preparations and visualized them using transmis-
sion electron microscopy. Preparation F contained parti-
cles of at least three different sizes: 80-120 nm HIV-1
virions (closed arrowhead), 30-100 nm irregularly shaped
exosomes (open arrowhead), and larger other membrane
vesicles (arrow) (Figure 2A), with about 83.7 ± 4.3% exo-
somes and 15.8 ± 3.2% HIV-1 virions from a total of eight
randomly selected EM fields in multiple EM images. In
comparison, preparation S had 80 - 120 nm HIV-1 virions
free of any sizes of membrane vesicles (Figure 2B), with
4.3 ± 3.2% exosomes and 93.5 ± 5.7% HIV-1 virions.
Furthermore, we determined whether there were any
differences in the infectivity of these three virion prepara-
tions. To this end, we infected Jurkat cells with each of the
viruses of the same amount of RT activity and monitored
virus infection and replication in these cells. There were
little differences of viral replication kinetics among these
three virion preparations (Figure 1D). Thus, unlike the
findings from dendritic cells that exosomes-associated
HIV-1 virions are more infectious [21], these results indi-
cate that the presence of exosomes does not affect the
HIV-1 infectivity in Jurkat cells.
In summary, all these experiments show that HIV-1
virions obtained from the new protocol are free of
exosomes and provide conclusive evidence that HIV-1
budding and exosome secretion in Jurkat cells are inde-
pendent from each other. Of note are two other
published protocols that have also been shown to pro-
duce exosomes-free HIV-1 virions. One involves use of
Figure 2 EM micrographs. A. The virus preparation (F) was fixed, diluted 10-fold and negative stained for EM imaging. Open arrowhead:
exosomes; closed arrowhead: HIV-1 virions; arrows: membrane vesicles. B. The virus preparation S. Both images in A and B were representative
of multiple EM images.
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tion [31]. Besides its requirement of the special agent
iodixanol, the fractionation manipulation in this protocol
is quite laborious. The other protocol is to use CD45
magnetic beads to deplete CD45-containing exosomes
from HIV-1 virion preparations [28]. This protocol is
clearly not applicable to analysis of exosomes and HIV-1
virions produced from cells that express little or no
CD45. Thus, this study not only presents a simplified
way to obtain highly purified HIV-1 virions free of exo-
somes or other cellular vesicles for basic HIV-1 virologi-
cal studies, but also provides a technical platform that
can be employed to further define the relationship
between HIV-1 budding and exosome biogenesis in other
HIV-1 target cells such as macrophages and dendritic
cells and its contributions to HIV-1 pathogenesis.
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